Susquehanna International Group
GEN

Susquehanna International Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Susquehanna International Group’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,400
Closed -$82K – 10447
2015
Q2 		$82K Sell
12,400
-14,800
-54% -$99.8K ﹤0.01% 9744
2015
Q1 		$194K Buy
+27,200
New +$205K ﹤0.01% 8659

Other funds holding GEN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group's GEN Position: Q2 2020 in Review

Susquehanna International Group sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 24,960 shares — an estimated $21K sold.

Susquehanna International Group first reported a position in GEN in Q1 2015 and held it in 10 quarters. The position peaked at $157K in Q4 2016. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

  • Susquehanna International Group reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
  • Susquehanna International Group sold 24,960 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $21K.
  • Susquehanna International Group first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 10 quarters.
  • Susquehanna International Group's Genesis Healthcare, Inc. position peaked at $157K in Q4 2016.
  • 58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.